Login / Signup

Impact of the COVID-19 Pandemic on a Program to Screen for Subclinical Familial Pulmonary Fibrosis.

Margaret L SalisburyCheryl R MarkinTisra H FadelyAdam R GuttentagJonathan A KropskiTimothy S Blackwell
Published in: American journal of respiratory and critical care medicine (2024)
Keyphrases
  • pulmonary fibrosis
  • quality improvement
  • high throughput
  • early onset
  • single cell